VIVES Partners
Venture capitalWavre · Pre-Seed–Series B · 4 people tracked
Investment thesis
VIVES is a venture capital fund initiated by UCLouvain that backs and supports university spin-offs and technology startups.
Source: firm website, verified Aug 3, 2026.
Team · 4 people
from public directoriesWhat they invest in
from 14 of 30 portfolio companiesBiotech ×8Healthtech ×5AgTech ×3Medical Devices ×3AI & Machine Learning ×2Deep Tech ×2Digital Health ×2Hardware ×2
HQs:Belgium×4Switzerland×1United States×1
Investments · 30 tracked
founders shown can be your intro pathBionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation mono and multispecific antibodies for severe immune-mediated inflammatory diseases, with an initial focus on atopic dermatitis and inflammatory bowel disease.
BiotechHealthtech
Frédéric Marrache(Co-founder & CEO)
3D-Side provides an AI-powered web platform for 3D preoperative planning and the creation of patient-specific medical devices, connecting doctors, patients, and medical device companies.
AI & Machine LearningDigital HealthMedical Devices
ATB Therapeutics develops targeted antibody therapies, including its "atbody" format, for hematological malignancies, autoimmune diseases, and solid tumors.
BiotechHealthtech
Axinesis develops neurorehabilitation devices that deliver intensive, gamified functional therapy for patients with motor and cognitive disorders, including stroke and cerebral palsy.
Digital HealthMedical DevicesRobotics
BiocSol develops microbial-free biopesticides that combine active compounds with complementary mechanisms of action to help farmers protect crops as an alternative to synthetic pesticides.
AgTechBiotechCleantech
Clinical-stage biopharmaceutical company developing next-generation biologics for severe immune-mediated inflammatory diseases.
Paris-based medtech startup (founded 2020) developing a long-term mechanical assist device.
Leader in high-temperature semiconductor solutions for power management and conversion.
e-peas develops energy harvesting power management ICs (ambient energy managers) and low-power microcontrollers that improve the autonomy of intelligent devices for markets including smart home, consumer electronics, and industrial IoT.
EnergyHardwareIoTSemiconductorsLouvain-la-Neuve, BE
Geoffroy Gosset(CEO & Co-founder)Julien De Vos(CTO & Co-founder)Christian Ferrier(CMO - Chief Marketing Officer)Coralie Brancart(CFO - Chief Financial Officer)Abdelali Lotfi(Sr VP Operations and Global Supply)
Eligo Bio works on the role of bacterial genes in triggering or worsening disease, applying genetic causality across a range of therapeutic areas.
BiotechDeep TechHealthtech
UCLouvain spin-off supported by the Louvain Technology Transfer Office.
Transforms microbial DNA complexity into a scalable platform for drug discovery.
Belgian UCLouvain spin-off (founded 2004) designing and commercializing turnkey biogas installations.
Independent technology provider with expertise in video processing and image compression.
Targets the tumor microenvironment to strengthen immune cell efficacy in eradicating cancer.
Cambridge, US
Michel Detheux(Executive Officer, Director)David Hallal(Director)Priyanka Belawat(Director)CHris Buyse(Director)Jonathan Skipper(Director)
BoardDetlev Biniszkiewicz(Director)in
Co-founded in the late 1990s with UCLouvain researchers, focused on neurotechnology.
UCLouvain spin-off in regenerative medicine, founded in 2013 by Drs Denis Dufrane and Jean-François Pollet.
Develops cell-based therapies to reduce the need for liver transplantation.
Provider of innovative control modules for dynamic outdoor lighting, maximizing energy savings.
UCLouvain spin-off developing quantitative analysis of an oxygen-sensitive blood biomarker to measure endothelial dysfunction.
Develops novel SV2A modulators building on UCB's research heritage.
Combines fixed and mobile networks to boost DSL speed with 4G, delivering 'hybrid internet'.
The Akkermansia Company develops postbiotic supplements built around a pasteurized form of the gut bacterium Akkermansia muciniphila (Akkermansia MucT), sold direct to consumers to support gut barrier integrity, weight management, and overall wellness.
Direct to ConsumerLongevityWellness & Fitness
Viridaxis is a Belgian company that mass-produces parasitoids and beneficial insects to control aphids using a plant-less rearing process, offering an alternative to chemical pesticides.
AgTechBiotechClimate TechGosselies, BE
Develops innovative antiviral technologies to fight viral diseases in livestock.
VOCSens builds ultra-low-power, selective multi-gas microsensors based on its patented CMOSEnvi semiconductor technology, along with EnviSoft software to convert gas concentration data into business insights.
HardwareIoTSemiconductorsLouvain-la-Neuve, BE
Frequently asked questions
- What stage does VIVES Partners invest at?
- VIVES Partners invests at the Pre-Seed, Seed, Series A, Series B stages.
- What is VIVES Partners's typical check size?
- VIVES Partners typically writes checks of $108K – $7.6M.
- What sectors does VIVES Partners focus on?
- VIVES Partners focuses on AgTech, Biotech, Climate Tech, Deep Tech, FoodTech, Hardware, Healthtech, Medical Devices, Sector Agnostic.
- Where is VIVES Partners located?
- VIVES Partners is headquartered in Wavre, BE.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
UntroD Capital is a deep-tech-focused investment firm that backs research-and-development-driven startups whose innovative technologies address challenges facing the planet and humanity, an approach it terms 'Real Tech'.
Clave is a private equity/venture capital manager with 20 years of experience and more than 90 investments made, actively participating in the strategy and management of its portfolio companies.
Innovation Industries is a deep tech investor backing companies with ground-breaking technologies aimed at addressing fundamental global challenges, providing support to help them scale and maximize environmental, social, and economic impact.
The Business Development Bank of Canada (BDC) is a Canadian institution that has supported small and medium-sized businesses for over 80 years, providing financing and advisory services to entrepreneurs across all industries and growth stages.